Adipokine genes and prostate cancer risk

International Journal of Cancer

Volumn 124, Issue 4, 2009, Pages 869-876

  Moore, Steven C ^a,b,h   Leitzmann, Michael F ^a,c   Albanes, Demetrius ^a   Weinstein, Stephanie J ^a   Snyder, Kirk ^d   Virtamo, Jarmo ^e   Ahn, Jiyoung ^a   Mayne, Susan T ^b   Yu, Herbert ^b   Peters, Ulrike ^f   Gunter, Marc J ^a,g  

^a NATIONAL CANCER INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^d INFORMATION MANAGEMENT SERVICES INC   (United States)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^f UNIVERSITY OF WASHINGTON   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h NONE   (United States)

Author keywords

Adipokines; Cytokines; Epidemiology; leptin; Prostate cancer

Indexed keywords

ADIPONECTIN; INSULIN; INTERLEUKIN 6; LEPTIN; LEPTIN RECEPTOR; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; ADIPOCYTOKINE; CYTOKINE;

ADULT; ALLELE; ARTICLE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FOLLOW UP; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; FINLAND; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; RISK;

ADIPOKINES; ADIPONECTIN; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; CYTOKINES; FINLAND; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; LEPTIN; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RECEPTORS, LEPTIN; RISK; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58149468081     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24043     Document Type: Article

References (54)

1. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343:78-85.
2. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, Yu K, Chatterjee N, Welch R, Hutchinson A, Crenshaw A, Cancel-Tassin G, et ai. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 2008:40:310-5.
3. Yeager M, Orr N. Hayes RB. Jacobs KB, Kraft P, Wacholder S. Minichiello MJ, Fearnhead P, Yu K, Chatterjee N, Wang Z, Welch R, et ai. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007;39:645-9.
4. Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ, Flores-Riveros JR. Biological action of leptin as an angiogenic factor. Science 1998;281:1683-6.
5. Rajala MW, Scherer PE. Minireview: the adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003:144:3765-73.
6. Mistry T, Digby JE, Desai KM, Randeva HS. Obesity and prostate cancer: a role for adipokines. Eur Urol 2007;52:46-53.
7. Bursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC. Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med 2003;54:131-52.
8. Colbert LH, Mai V, Perkins SN, Berrigan D, Lavigne JA, Wimbrow HH, Alvord WG, Haines DC, Srinivas P, Hursting SD. Exercise and intestinal polyp development in APCMin mice. Med Sci Sports Exerc 2003;35:1662-9.
9. Larsson H, Elmstahl S, Bergiund G, Ahren B. Evidence for leptin regulation of food intake in humans. J Clin Endocrinol Metab 1998; 83:4382-5.
10. Reidy SP, Weber J. Leptin: an essential regulator of lipid metabolism. Comp Biochem Physiol A Mol Integr Physiol 2000;125:285-98.
11. Stattin P, Soderberg S, Hallmans G, Bylund A, Kaaks R, Stenman UH, Bergh A, Olsson T. Leptin is associated with increased prostate cancer risk: a nested case-referent study. J Clin Endocrinol Metab 2001;86:1341-5.
12. Gade-Andavolu R, Cone LA, Shu S, Morrow A, Kowshik B, Andavolu MV. Molecular interactions of leptin and prostate cancer. Cancer J 2006;12:201-6.
13. Hsing AW, Chua S Jr, Gao YT, Gentzschein E, Chang L, Deng J, Stanczyk FZ. Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst 2001 ;93:783-9.
14. Stattin P, Kaaks R, Johansson R, Gislefoss R, Soderberg S, Alfthan H, Stenman UH, Jellum E, Oisson T. Plasma leptin is not associated with prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2003; 12; 474-5.
15. Baillargeon J, Platz EA, Rose DP, Pollock BH, Ankerst DP, Haffner S, Higgins B, Lokshin A, Trover D, Hernandez J, Lynch S, Leach RJ, et al. Obesity, adipokines, and prostate cancer in a prospective population-based studv. Cancer Epidemiol Biomarkers Prev 2006; 15:1331- 5.
16. Ribeiro R, Vasconcelos A, Costa S, Pinto D, Morais A, Oliveira J, Lobo F, Lopes C, Medeiros R. Overexpressing leptin genetic polymorphism (-2548 G/A) is associated with susceptibility to prostate cancer and risk of advanced disease. Prostate 2004;59:268-74.
17. Goktas S, Yilmaz MI, Caglar K, Sonmez A, Kilic S, Bedir S. Prostate cancer and adiponectin. Urology 2005;65:1168-72.
18. Michalakis K, Williams CJ, Mitsiades N, Blakeman J, Balafouta-Tseienis S, Giannopoulos A, Mantzoros CS. Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study. Cancer Epidemiol Biomarkers Prev 2007;16:308-13.
19. McCarron SL, Edwards S, Evans PR, Gibbs R, Dearnaley DP, Dowe A, Southgate C, Easton DF, Eeles RA, Howell WM. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res 2002:62:3369-72.
20. Wu HC, Chang CH, Chen HY, Tsai FJ, Tsai JJ, Chen WC. p53 gene codon 72 polymorphism but not tumor necrosis factor-alpha gene is associated with prostate cancer. Urol Int 2004;73:41-6.
21. Midlaud DS, Daugherty SE, Berndt SI, Platz EA, Yeager M, Crawford ED, Hsing A, Huang WY, Hayes RB. Genetic polymorphisms of interleukin-1B (IL-1B). IL-6. IL-8. and IL-10 and risk of prostate cancer. Cancer Res 2006;66:4525-30.
22. Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, Hartman AM, Palmgren J, Freedman LS, Haapakoski J, Barrett MJ, Pietinen P, et al. Alpha-tocopheroi and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996;88:1560-70.
23. Korhonen P, Malila N, Pukkala E, Teppo L, Albanes D, Virtamo J. The Finnish Cancer Registry as follow-up source of a large trial cohort-accuracy and delay. Acta Oncol 2002;41:381-8.
24. Woodson K, Tangrea JA, Pollak M, Copeland TD, Taylor PR, Virtamo J, Albanes D. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men. Cancer Res 2003;63:3991-4.
25. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-9.
26. Kote-Jarai Z, Singh R, Durocher F, Easton D, Edwards SM, Rdern-Jones A, Dearnaley DP, Houlston R, Kirby R, Eeles R. Association between leptin receptor gene polymorphisms and early-onset prostate cancer. BJU Int 2003;92:109-12.
27. Larsson H, Elmstahl S, Bergiund G, Ahren B. Evidence for leptin regulation of food intake in humans. J Clin Endocrinol Metab 1998;83: 4382-5.
28. Chokkalingam AP, Stanczyk FZ, Reichardt JK, Hsing AW. Molecular epidemiology of prostate cancer: hormone-related genetic loci. Front Biosci 2007;12:3436-60.
29. van der LT, Te Pas MF, Veerkamp RF, Liefers SC. Leptin gene polymorphisms and their phenotypic associations. Vitam Horm 2005; 71:373-404.
30. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD, Diehl AM. Leptin regulates proinflammatory immune responses. FASEB J 1998; 12: 57-65.
31. Bouloumie A, Drexler HC, Lafontan M, Busse R. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 1998;83:1059-66.
32. Nazian SJ, Cameron DF. Temporal relation between leptin and various indices of sexual maturation in the male rat. J Androl 1999; 20:487-91.
33. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougneres P, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392:398-401.
34. Mantzoros CS, Flier JS, Rogol AD. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of pubertv. J Clin Endocrinol Metab 1997;82:1066-70.
35. Ribeiro R, Lopes C, Medeiros R. The link between obesity and prostate cancer: the leptin pathway and therapeutic perspectives. Prostate Cancer Prostatic Dis 2006:9:19-24.
36. Ribeiro R, Lopes C, Medeiros R. Leptin and prostate: implications for cancer prevention-overview of genetics and molecular interactions. Eur J Cancer Prev 2004:13:359-68.
37. Chang S, Hursting SD, Contois JH, Strom SS, Yamamura Y, Babaian RJ, Troncoso P, Scardino PS, Wheeler TM, Amos CI, Spitz MR. Leptin and prostate cancer. Prostate 2001 ;46:62-7.
38. Giles GG, Severi G, English DR, McCredie MR, MacInnis R, Boyle P, Hopper JL. Early growth, adult body size and prostate cancer risk. Int J Cancer 2003; 103:241-5.
39. Hayes RB, de Jong FH, Raatgever J, Bogdanovicz J, Schroeder FH, van der MP, Oishi K, Yoshida O. Physical characteristics and factors related to sexual development and behaviour and the risk for prostatic cancer. Eur J Cancer Prev 1992; 1:239-45.
40. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human horaologue. Nature 1994:372:425-32.
41. Mammes O, Betoulle D, Aubert R, Giraud V, Tuzet S, Petiet A, Colas-Linhart N, Fumeron F. Novel polymorphisms in the 5' region of the LEP gene: association with leptin levels and response to lowcalorie diet in human obesity. Diabetes 1998;47:487-9.
42. Hoffstedt J, Eriksson P, Mottagui-Tabar S, Arner P. A polymorphism in the leptin promoter region (-2548 G/A) influences gene expression and adipose tissue secretion of leptin. Horm Metab Res 2002;34:355- 9.
43. Yiannakouris N, Melistas L, Yannakoulia M, Mungal K, Mantzoros CS. The-2548G/A polymorphism in the human leptin gene promoter region is associated with plasma free leptin levels; interaction with adiposity and gender in healthy subjects. Hormones (Athens) 2003:2: 229-36.
44. Hager J, Clement K, Francke S, Dina C, Raison J, Lahlou N, Rich N, Pelloux V, Basdevant A, Guy-Grand B, North M, Froguel P. A polymorphism in the 5' untranslated region of the human ob gene is associated with low leptin levels. Int J Obes Relat Metab. Disord 1998:22:200-5.
45. Li WD, Reed DR, Lee JH, Xu W, Kilker RL, Sodam BR, Price RA. Sequence variants in the 5' flanking region of the leptin gene are associated with obesity in women. Ann Hum Genet 1999;63(Pt 3);227-34.
46. Wang TN, Huang MC, Chang WT, Ko AM, Tsai EM, Liu CS, Lee CH, Ko YC. G-2548A polymorphism of the leptin gene is correlated with extreme obesity in Taiwanese aborigines. Obesity (Silver Spring) 2006;14:183-7.
47. Marames O, Betoulle D, Aubert R, Herberth B, Siest G, Furaeron F. Association of the G-2548A polymorphism in the 5' region of the LEP gene with overweight. Ann Hum Genet 2000;64(Pt 51:391-4.
48. Jiang Y, Wilk JB, Borecki I, Williamson S, DeStefano AL, Xu G, Liu J, Ellison RC, Province M, Myers RH. Common variants in the 5' region of the leptin gene are associated with body mass index in men from the National Heart, Lung, and Blood Institute Family Heart Study. Am J Hum Genet 2004;75:220-30.
49. Matinspector, Genomatix software. [Internet] 2008 [cited 2008 October 27]. Available from: http://www genomatix de/products/MatTnspector/ index html. 2008.
50. Frazer KA, Bailinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, Belmont JW, Boudreau A, Hardenbol P, Leal SM, Pasternak S, Wheeler DA, et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007;449:851-61.
51. Chu NF, Spiegelman D, Hotamisligil GS, Rifai N, Stampfer M, Rimm EB. Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atherosclerosis 2001; 157:495-503.
52. Kaplan RC, Ho GY, Xue X, Rajpathak S, Cushman M, Rohan TE, Strickier HD, Scherer PE, Anastos K. Within-individual stability of obesity-related biomarkers among women. Cancer Epidemiol Biomarkers Prev 2007; 16:1291-3.
53. Kaaks R, Lukanova A, Rinaldi S, Biessy C, Soderberg S, Oisson T, Stenman UH, Riboli E, Hallmans G, Stattin P. Interrelationships between plasma testosterone, SHBG, TGF-T, insulin and leptin in prostate cancer cases and controls. Eur J Cancer Prev 2003;12:309-15.
54. Smith GD, Lawlor DA, Harbord R, Timpson N, Day I, Ebrahim S. Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PLoS Med 2007;4:e352.